株式会社極東書店トップ商品一覧Purine and Pyrimidine Metabolism in Man X. 1st ed. Softcover of orig. ed. 2001

商品詳細

Purine and Pyrimidine Metabolism in Man X. 1st ed. Softcover of orig. ed. 2001

Purine and Pyrimidine Metabolism in Man X. 1st ed. Softcover of orig. ed. 2001

・ISBN 978-1-4419-3353-9 paper EUR 199.99

¥53,456.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
著者・編者Zoref-Shani, Esther / Sperling, Oded (eds.),
シリーズ (Advances in Experimental Medicine and Biology)
出版社 (Springer-Verlag New York Inc., US)
出版年月2010
ページ数424 pp.
言語ENG
ニュース番号<A05-45158>

解説

th This volume contains articles presented at the X International Symposium on Purines and Pyrimidines in Man, held on May 14 19, 2000 in Tel Aviv, Israel. The first symposium in this series took place in Tel Aviv in 1973. Since then, the symposium has been held every three years in different parts of the world, including Europe, USA and Japan. The participants, in this series of symposia, are characterised by a wide interest in the various aspects of purines and pyrimidines in man, which include biochemistry, genetics, pharmacology, physiology, clinics, etc. Presentations in the symposia include clarification of metabolic pathways, characterisation of enzyme structure and kinetics and discoveries of new inborn errors of metabolism and suggestions for new therapeutic approaches for these inborn errors. In addition, development of new purine and pyrimidine derivatives for the treatment of cancer and viral diseases, and many more subjects of mutual interest were brought to the fore. With the development of therapeutic means and of new research tools, we have witnessed changes in the areas of interest. The interest in gout and uric acid urolithiasis has lessened, whereas molecular aspects, the role of purine and pyrimidine substances in neurotransmission and in purinergic signaling appear to gain greater interest. The articles, included in this volume, contain new data pertaining to the various aspects detailed above.